Changes in the aortic endothelium and plasma von Willebrand factor levels during the onset and progression of insulin-dependent diabetes in BB rats

Atherosclerosis

Volumn 139, Issue 2, 1998, Pages 291-299

  Ribau, José C O ^a   Hatton, Mark W C ^a   Richardson, Mary ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

BB rats; Diabetes mellitus; Endothelium; Morphology; Von Willebrand Factor

Indexed keywords

VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA INTIMA; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOIMMUNITY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; VASCULAR DISEASE;

ANIMALS; AORTA; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, INBRED BB; TISSUE DISTRIBUTION; TUNICA INTIMA; VON WILLEBRAND FACTOR;

EID: 0031877653     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00082-3     Document Type: Article

References (40)

1. Eschwege E., Balkau B., Fontbonne A. The epidemiology of coronary heart disease in glucose-intolerant and diabetic subjects. J Intern Med. 236(Suppl 736):1994;5-11.
2. Lorenzi M., Cagiero E. Pathobiology of endothelial and other vascular cells in diabetes mellitus. Call for data. Diabetes. 40:1991;653-659.
3. Lambert J., Aarsen M., Donker A.J.M., Stehouwer C.D.A. Endothelium-dependent and -independent vasodilation of large arteries in microalbuminric insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 16:1996;705-711.
4. Cohen R.A. Dysfunction of vascular endothelium in diabetes mellitus. Circulation. 87:1993;V67-V76.
5. 2. Am J Physiol. 257:1989;H1327-H1332.
6. Cameron N.E., Cotter M.A. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia. 35:1992;1011-1019.
7. McNamee C.J., Kappagoda C.T., Kunjara R., Russell J.C. Defective endothelium-dependent relaxation in the JCR:LA-corpulent rat. Circ Res. 74:1994;1126-1132.
8. Juhan-Vague I., Roul C., Alessi M.C., Ardissone J.P., Heim M., Vague P. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients: Relationship with plasma insulin. Thromb Haemost. 61:1989;370-373.
9. Winocour PD, Richardson M. Thrombosis and atherogenesis in diabetes. In: Draznin B, Eckel R, editors. Diabetes and Atherosclerosis: Molecular Basics and Clinical Aspects. Amsterdam: Elsevier, 1993:213.
10. Gonzalez J., Colwell J.A., Sarji K.E. Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:vWF) in diabetes mellitus. Thromb Res. 17:1980;261-266.
11. Paton R.C., Kernoff P.B.A., Wales J.K. Effects of diet and glicazide on the hemostatic system of non-insulin dependent diabetics. Br Med J. 283:1981;1018-1020.
12. Winocour P.D., Lopes-Virella M., Laimins M. Effect of insulin treatment in streptozotocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand activity and factor VIII-related antigen. J Lab Clin Med. 106:1985;319-325.
13. Ruggeri Z.M., Ware J. The structure and function of von Willebrand factor. Thromb Haemost. 67:1992;594-599.
14. Wagner D.D. The Weibel-Palade body: The storage granule for von Willebrand factor and P-selectin. Thromb Haemost. 70:1993;105-110.
15. Greaves M., Malia R.G., Ward A.M. Elevated von Willebrand factor antigen in systemic sclerosis: Relationship to visceral disease. Br J Rheumatol. 27:1988;281-285.
16. Sadler J.E. von Willebrand factor. J Biol Chem. 266:1991;22777-22780.
17. Blann A.D., McCollum C.N. Von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg. 8:1994;10-15.
18. Lufkin E.G., Fass D.N., O'Fallon W.M., Bowie E.J.W. Increased von Willebrand factor in diabetes mellitus. Metabolism. 28:1979;63-66.
19. Hadcock S., Richardson M., Winocour P.D., Hatton M.W.C. Intimal alterations in the first six months of alloxan-induced diabetes. Arterioscler Thromb. 11:1991;517-529.
20. Richardson M., Hadcock S.J., DeReske M., Cybulsky M.I. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb. 14:1994;760-769.
21. Argobast B.W., Berry D.L., Newell C.L. Injury of arterial endothelial cells in diabetic, sucrose-fed and aged rats. Atherosclerosis. 51:1984;31-45.
22. Reinila A. Long-term effects of untreated diabetes on the arterial wall in rats: An ultrastructural study. Diabetologia. 20:1981;205-212.
23. Lin S.-J., Hong C.-Y., Chang M.-S., Chiang B.N., Chien S. Increased aortic endothelial cell death and enhanced transendothelial macromolecular transport in streptozotocin-diabetic rats. Diabetologia. 36:1993;926-930.
24. Mordes J.P., Desemone J. Rossini A.A. The BB rat. Diab Metab Rev. 3:1987;725-750.
25. Meraji S., Jayakody L., Manohara P.J.S., Thompson A.B.R., Kappagoda T. Endothelium-dependent relaxation in aorta of BB rat. Diabetes. 36:1987;978-981.
26. Pieper G.M., Moore-Hilton G., Roza A.M. Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci. 58:1996;147-152.
27. Aster R.H., Jandl J.H. Platelet sequestration in man. J Clin Invest. 43:1964;843-854.
28. Richardson M., Tinlin S., De Reske M., Webster S., Senis Y., Giles A.R. Morphological alterations in endothelial cells associated with the release of von Willebrand factor after thrombin generation in vivo. Arterioscler Thromb. 14:1994;990-999.
29. Toh C.H., Hoogendoorn H., Giles A.R. The generation of thrombin in vivo induces the selective loss of high molecular weight multimers of von Willebrand factor and the reversible sequestraton of platelets. Br J Haematol. 85:1993;751-760.
30. Ueda N., Shah S.V. Apoptosis. J Lab Clin Med. 48:1994;25-34.
31. Reidy M.A., Schwartz S.M. Endothelial injury and regeneration IV. Endotoxin: A nondenuding injury to aortic endothelium. Lab Invest. 48:1983;25-34.
32. Bar R. Vascular endothelium and diabetes mellitus. In: Simionescu M, Simionescu N, editors. Endothelial Cell Dysfunctions. New York: Plenum Press, 1992:363.
33. Wagner D.D., Marder V.J. Biosynthesis of von Willebrand protein by human endothelial cells: Processing steps and their intracellular localization. J Cell Biol. 99:1984;2123-2130.
34. Sporn L.A., Mader V.J., Wagner D.D. Inducible secretion of large biologically potent von Willebrand factor mulitmers. Cell. 46:1986;185-190.
35. Anderson H.R., Stitt A.W., Gardiner T.A., Archer D.B. Stereological estimation of Weibel-Palade bodies in the retinal vasculature of normal and diabetic dogs. Curr Eye Res. 13:1994;705-710.
36. Trillo A.A., Prichard R.W. Early endothelial changes in experimental primate atherosclerosis. Lab Invest. 41:1979;294-302.
37. McNiff J.M., Gill J. Secretion of Weibel-Palade bodies observed in extra-alveolar vessels of rabbit lung. J Appl Physiol. 54:1983;1248-1286.
38. Ibbotson S., Catto A., Davies A., Grant P. The effect of insulin-induced hypoglycaemia on factor VIII:C concentrations and thrombin activity in subjects with type I (insulin dependent) diabetes. Thromb Haemost. 73:1995;243-246.
39. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 318:1988;1315-1321.
40. Winocour P.D., Kinlough-Rathbone R.L., Mustard J.F. Platelet survival in rats with spontaneous diabetes mellitus. J Lab Clin Med. 109:1987;464-468.